Sign in
4

Changes in Ownership

HERON THERAPEUTICS, INC. /DE/ Filed Acc 0001209191-21-057420

Director sold 300 shares at $12.31 ($3,692)

From the SEC's structured data for this filing

Trades in this filing

Table I: Non-derivative

Insider Date Transaction Shares Price Value Owned after D/I
Christian Waage Director 2021-09-21 Sale −300 $12.31 $3,692 3,500 D: show line 1 in the form
Open-market sales · 300 sh · avg $12.31 · $3,692
Loading xslF345X03/doc4.xml…